Opportunity ID: 279026

General Information

Document Type: Grants Notice
Funding Opportunity Number: ONDCP-DEW-2015
Funding Opportunity Title: Drug Early Warning from Re-Testing Biological Samples
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 95.007 — Research and Data Analysis
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 16, 2015
Last Updated Date:
Original Closing Date for Applications: Sep 22, 2015
Current Closing Date for Applications: Sep 22, 2015
Archive Date: Oct 22, 2015
Estimated Total Program Funding: $100,000
Award Ceiling: $100,000
Award Floor: $100,000

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Additional Information on Eligibility: ONDCP encourages applications from public nonprofit institution/organization (includes institutions of higher education and hospitals). Applicants must have expert knowledge and extensive experience in conducting research and analysis. Current awardee is eligible to apply for this funding opportunity.

Additional Information

Agency Name: Office of National Drug Control Policy
Description: The Office of National Drug Control Policy (ONDCP), Executive Office of the President, is seeking applications from public nonprofit institutions/organizations (includes institutions of higher education and hospitals) to perform research and analysis of data to inform drug policy. This project seeks to further refine a methodology for obtaining drug early warning indicators from expanded testing of urine samples that were previously collected and tested as part of an existing drug test protocol. This method was initially developed using local criminal justice populations – including persons in pre-trial or lock-up, parolees or probationers, and drug court participants. Similar methodology is promising for use in other venues, such as in trauma units and emergency departments, where biological samples are often collected from patients. Before the specimens are discarded, the project will re-test them for an expanded panel of drugs, including synthetic cannabinoids, to determine what old and new illicit drugs are detected or missed by conventional testing protocols, and how the drug patterns might vary by subpopulation and geography. By passing the expense of collecting the original specimens and re-using those that have already been tested with known results yields a relatively inexpensive and timely picture of emerging drugs in a given subpopulation and locality. ONDCP expects to continue to engage the laboratory testing services of the Armed Forces Medical Examiner System (AFMES) at no charge to further minimize project costs.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

darren neely

IT specialist

Phone 2023955530
Email:dneely@ondcp.eop.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: darren neely
IT specialist
Phone 2023955530
Email: dneely@ondcp.eop.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
95.007 PKG00218555 Sep 16, 2015 Sep 22, 2015 View

Package 1

Mandatory forms

279026 SF424_2_1-2.1.pdf

279026 Project-1.1.pdf

279026 Budget-1.1.pdf

279026 SF424B-1.1.pdf

2025-07-09T16:21:55-05:00

Share This Post, Choose Your Platform!

About the Author: